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Background: Dental caries is the most prevalent oral disease in several Asian and Latin American countries. It is an
infectious disease and different types of bacteria are involved in the process. Synthetic antimicrobials are used
against this disease; however, many of these substances cause unwarranted undesirable effects like vomiting,
diarrhea and tooth staining. Propolis, a resinous substance collected by honeybees, has been used to control the
oral microbiota. So, the objective of this study was to develop and characterize sustained-release propolis-based
chitosan varnish useful on dental cariogenic biofilm prevention, besides the in vitro antimicrobial activity.
Methods: Three formulations of propolis - based chitosan varnish (PCV) containing different concentrations (5%,
10% and 15%) were produced by dissolution of propolis with chitosan on hydro-alcoholic vehicle. Bovine teeth
were used for testing adhesion of coatings and to observe the controlled release of propolis associated with
varnish. It was characterized by infrared spectroscopy, scanning electron microscopy, casting time, diffusion test
in vitro antimicrobial activity and controlled release. Minimum inhibitory concentration (MIC) and minimum
bactericidal concentration (MBC) were tested for the main microorganisms involved in the cariogenic biofilm
through the microdilution test in 96-well plates.
Results: The formulations presented a tooth surface adherence and were able to form films very fast on bovine
tooth surface. Also, propolis-based chitosan varnishes have shown antimicrobial activity similar to or better than
chlorhexidine varnish against all oral pathogen bacteria. All microorganisms were sensitive to propolis varnish and
chitosan. MIC and MBC for microorganisms of cariogenic biofilme showed better results than chlorhexidine. Propolis
active components were released for more than one week.
Conclusion: All developed formulations turn them, 5%, 10% and 15% propolis content varnish, into products suitable
for clinical application on dental caries prevention field, deserving clinical studies to confirm its in vivo activity.
Keywords: Propolis, Chitosan, Varnish, Drug delivery, Cariogenic biofilm, Prevention, Oral microorganismsBackground
Dental caries is the most prevalent oral disease in several
Asian and Latin American countries, despite the signifi-
cant decline in many developed countries over recent
decades [1-4]. Moreover, it is expected to increase in
many developing countries in Africa [5-7]. Although its* Correspondence: vegneer2003@yahoo.com.br
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unless otherwise stated.incidence is particularly high during childhood [3,8-10],
people are susceptible throughout their lifetime [11,12].
Dental caries is an infectious disease, the development
of which is a dynamic process involving alternating
demineralization and remineralization, rather than uni-
directional demineralization [13]. Demineralization of
tooth structure is caused by the organic acids produced
in dental plaque biofilm by the metabolic action of the
cariogenic microorganisms on fermentable carbohy-
drates [14,15]. Formation of biofilm is a biological
process associated with the attachment, detachmentThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Chemical composition* of the green Propolis
extract
Component Quantity (mg/g) Component Quantity (mg/g)




Quercetin 1.38 Crisin 3.51
Kaempferol 1.77 Galangine 9.75
Isoramnetin 0.91 Kaempferide 11.60
Sakuranetin 5.57 Artepillin-C 82.96
*PharmaNectar, Brazil, 2007.
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The dental biofilm is formed via adhesion of planktonic
bacteria to a protein pellicle coating the tooth surfaces
[16,17]. Many types of bacteria participate in the forma-
tion of the dental biofilm [18]. Dental caries is caused
by the interaction, over the time, of bacteria that produce
acids with a substrate that the bacteria can metabolize and
many host factors that include teeth and saliva [19]. There
are only a few groups of microorganisms that can adhere
to the teeth, which includes mutans Strepcococci group,
Lactobacillus and some Actinomyces species [20,21]. More
than five Streptococcus species and Actinomyces viscosus
are regarded as early colonizers of tooth surfaces, while
mutans Streptococci such as S. sobrinus, S. salivarius, S.
sanguinis and S. mutans are considered middle important
colonizers of the dental biofilm [19]. The inhibition of
plaque biofilm formation is the key to successful control
and prevention of dental caries. Previous antibacterial
mouth rinses, which generally contain fluorides, alcohols,
detergents and other antimicrobial substances, effectively
reduce plaque formation. Synthetic antimicrobials used in
tooth pastes and mouth rinses include povidone iodine
products, chlorhexidine, cetylpyridinium chloride, tri-
closan and zinc citrate [22,23]. However, many of these
substances cause unwarranted undesirable effects like
vomiting, diarrhea and tooth staining. Prevention, based
on common risk factors, plays an important role on car-
ies management [24,25] and recent studies have shown
the anti-caries activity of different natural products such
as propolis [26,27].
Propolis is a resinous substance collected by honey-
bees from buds and exudates of certain trees and plants
and stored inside their hives. It has been used in folk
medicine from ancient times to treat various ailments
[28]. Propolis has been used for centuries by world
population due to its pharmacological properties such as
anti-inflammatory, healing, antimicrobial and antioxi-
dant [29]. In dentistry, propolis has been used to control
the oral microbiota [30]. The antibacterial activity of
propolis is reported due to flavonoids, aromatic acids,
and esters present in resins. Galangin, pinocembrin, and
pinostrobin are known as the most effective flavonoids
agents against bacteria. Ferulic acid and caffeic acid also
contribute to the bactericidal action of propolis [31].
Propolis has plenty of biological and pharmacological
properties and its mechanisms of action have been
widely investigated in the last years, using different ex-
perimental models in vitro and in vivo [26].
Another potential agent on caries prevention is chito-
san, which is a polysaccharide comprising copolymers of
glucosamine and N-acetyl- glucosamine [32]. Water-
soluble chitosan have proven to be active against Prevo-
tella gingivalis (MIC = 0.31 mg/mL) and Fusobacterium
nucleatum (0.08 mg/mL) [33]. In the same way, high-molecular weight and low molecular chitosan showed
activity against a sort of different anaerobic oral bacteria
like P. gingivalis (MIC = 1 and 1 mg/mL respectively), T.
forsythensis (MIC = 1 and 1 mg/mL respectively), P.
buccae (MIC = 3 and 1 mg/mL respectively), A. actino-
mycetemcomitans (MIC = 5 and 3 mg/mL respectively),
P. intermedia (MIC = 1 and 3 mg/mL respectively) and
S. mutans (MIC = 3 and 5 mg/mL respectively) [34]. Ad-
hesion of low molecular weight chitosan formulations
on tooth analogs was demonstrated [35,36]. Chitosan,
also, offers a flexible platform for designing coatings to
protect surfaces from infection, since it was been demon-
strated that chitosan-coated surfaces resists to biofilm of
Staphylococcus epidermidis, Staphylococcus aureus, Klebsi-
ella pneumoniae, Pseudomonas aeruginosa and Candida
albicans [37]. Varnishes are pharmaceutical formulations
that can form antimicrobial tooth film and protect the
tooth surface of caries [38]. Here, we report the develop-
ment, the characterization and antimicrobial activity of
sustained release chitosan-based propolis varnishes,for
possible use in the prevention of cariogenic biofilm.Methods
Propolis samples
Green propolis used in this study was collected during
spring, and obtained from a commercial beekeeping
named Pharmanéctar® registered at the National Agency
of Sanitary Surveillance (ANVISA register n° 17.226.994/
0001-61), in Minas Gerais State, Brazil. Botanical origin of
Brazilian green propolis was Baccharis dracunlifolia
[29,39]. Ethanolic propolis extract (EPE) was used in this
study and the chemical composition is shown in Table 1.
Crude propolis samples were further dehydrated with a
low-vacuum pump, and it was prepared as described [40].
The dried propolis samples were ground into fine powder,
and 2.5 g of propolis was mixed with 25 mL of 80% aque-
ous ethanol in a test tube and shaken at 70°C for 30 min.
After extraction, the mixture was centrifuged at 8000 × g
to obtain the supernatants, which were named alcoholic
propolis extract, which was used in this study.
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Chitosan of medium molecular weight (75-85% of desa-
cetylation) was purchase from Sigma-Aldrich (Michigan,
USA). Ethanol was purchased from Synth (Sao Paulo,
Brazil) and glacial acetic acid (100%) was purchased
from Merck (USA). Purified water was obtained from a
Milli-Q water purification system. All reagents used
were analytical grade. Brain Heart Infusion (BHI) broth,
BHI agar, rogosa broth, rogosa agar menadione and vita-
min K was purchased from Difco (USA). Chlorhexidine
0.12% varnish was purchased from Sigma (USA).
Varnishes preparation
Propolis-based chitosan varnishes (PCV) were prepared
by the addition of acetic acid to EPE 25%. After mixing,
medium molecular weight chitosan was added and water
was used to complete the formulation volume. Then, the
compositions were mixed overnight and the varnishes
formulations containing 5% w/v, 10% w/v and 15% w/v
of propolis (PCV 5%, PCV 10% and PCV 15%, respect-
ively) were developed and characterized. The chitosan
base varnish (CHV), used as blank varnish, were pre-
pared by the same method, using ethanol instead of EPE.
Varnish compositions are presented in Table 2. Final pH
of the formulation was between 4.0 and 5.0.
Attenuated total reflection fourier transform infrared
spectroscopic imaging (ATR-FTIR) analyses
Formulations, PCV, CHV and EPE were dried for
30 minutes in Petri dishes before ATR-FTIR analysis. The
spectra of the dried samples were recorded within films on
a PerkinElmer FTIR spectrometer, model Spectrum One.
Varnish casting time
Varnishes casting time was determined by applying
50 μL directly onto the buccal surface of incisive bovine
teeth using a sterile swab. Bovine teeth were donated by
specialized slaughterhouse authorized by the city of Belo
Horizonte in July 2010. The teeth were collected from
carcasses that would be incinerated, and the animals
were not the direct object of study and therefore notTable 2 Composition of the Propolis varnishes containing
15 w/v % (PCV 15%), 10 w/v % (PCV 10%) e 5% w/v %
(PCV 5%) of Propolis extract and of the blank varnish (BCV)
Component PCV 5% PCV 10% PCV 15% BCV
Propolis ethanolic
extract (25%)
20.0 mL 40.0 mL 60.0 mL -
Ethanol 40.0 mL 20.0 mL - 60.0 mL
Acetic acid 9.0 mL 9.0 mL 9.0 mL 9.0 mL
Chitosan 1.0 g 1.0 g 1.0 g 1.0 g
MilliQ water q.s.p. 100 mL 100 mL 100 mL 100 mLsubmitted to the Ethics Committee on Animal Research.
After the application, the time needed to form a com-
pletely casted film on tooth surface was determined. The
casting time was determined using or not compressed
air as casting agent. The test was performed in triplicate
in four teeth for each formulation.
Scanning electron microscopy (SEM) analysis
The morphology of the formed films on the tooth surface
was studied using a JEOL scanning electron microscope,
model JSM-6360LV, operating in 15 kV acceleration volt-
age. The samples were prepared by the application of
50 μL of the varnishes in incisive cow tooth using a swab.
After the formation of the completely casted films, the
teeth were broken and directly analyzed at suitable accel-
eration voltages for each sample, in different magnification
ranges. Representative micrographs were taken.
In vitro antimicrobial susceptibility test
The antimicrobial susceptibility test was made according to
the agar diffusion method [41]. Microorganisms S. mutans
(ATCC 25175), S. sanguinis (ATCC 10557), S. salivarius
(INCQS 00457), L. casei (ATCC 393), Aggregatibacter acti-
nomycetemcomitans (ATCC 33384), Porphyromonas gingi-
valis (ATCC 33277), Prevotella intermedia (ATCC 25611),
and Fusobacterium nucleatum (ATCC 23726) were used in
the experiment. Streptococci group was cultivated in BHI
broth and after 18 hours, was transferred into BHI agar
containing 5% sucrose. Lactobacillus casei was suspended
in Rogosa broth, and after 18 hours of growth were trans-
ferred to plates containing Rogosa agar. The other anaer-
obic microorganisms were suspended in BHI broth
supplemented with sheep blood and after 24 hours were
transferred to petri dishes containing BHI agar supple-
mented with sheep blood, 1% menadione and 1% vitamin
K. The inocula of all microorganisms were prepared by col-
lecting 3–5 colonies grown on agar after 24 hours and the
number of microorganism was calculated based on the
standard turbidity of 0.5 McFarland, corresponding to
1.0 × 108 colony forming units (CFU)/mL. Lactobacillus
and Streptococcus were grown at 37°C in atmosphere con-
taining 5% CO2, while other microorganisms were cultured
anaerobically at 37°C. Sterile paper blank discs containing
50 μL of each propolis varnish were placed on the agar.
CHV were used as negative control, chlorhexidine 0.12%
varnish (CHL) and EPE 5% were used as inhibition growth
positive controls. The inhibition of bacterial growth was de-
termined by measuring the diameter of inhibition zones
formed after 48 hours of incubation. The solvent effect was
annulated by casting the discs containing the samples
(PCV, CHV, CHL and EPE) before placing them in the agar.
MIC and MBC planktonic tests were made according to
the rules of Clinical and Laboratory Standards Institute
(CLSI, 2007) [41].
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Propolis release profile from formulations was studied in
3 mL of medium, which was a solution containing
20% v/v of ethanol in water, at 37°C. The samples were
prepared by the application of 40 μL (20 μL twice) of the
varnishes in incisive bovine teeth, previously cut in 0.5 ×
0.5 cm square pieces. After the formation of the com-
pletely casted films, the teeth were placed in tubes with
the same medium used before (3 mL of 20% v/v of etha-
nol in water). At scheduled time intervals (30 min, each
hour until eight hours, 24 h, and then, once a week until
the end of the release), samples were taken and the entire
medium volume (3 mL) was replaced with fresh medium
to maintain sink conditions. The amount of propolis re-
leased was quantified as total flavonoids content, mea-
sured as quercetin) [42]. UV/Vis spectroscopy at 425 nm
was used for flavonoids quantification and the method
was properly validated, according to ICH guidelines
before analysis (linear equation: y = 0.106722 × +0.0229511,
r2 = 0.9970, n = 5).
Statistical analysis
The statistical analyses were performed using GraphPad
PrismTM (version 5.0 for Windows). The data are repre-
sentative of three different experiments, which presented
similar results. UV-visible spectrophotometric assay was
determined by linear regression and the r2 value indi-
cated the measure of goodness-of-fit for linear regres-
sion. The Pearson normality test was used to determine
the normality of the data. Since the data were found to
be normally distributed, the Unpaired Student’s t-test
was used.
Results
Propolis and chitosan formed a completed mixed formula-
tion and no interfaces separation were find between var-
nish components.
ATR-FTIR analysis
ATR-FTIR spectrum of CHV (a), EPE (b) and PCV 15%
(c), after casting, are presented in Figure 1. In CHV
spectrum, it is possible to identify characteristic absorp-
tion bands of chitosan: an overlapped wide absorption
band at 3256 cm−1 due to the stretching vibration of the
O-H and N-H bonds; two bands at 1633 and 1539 cm−1,
which can be attributed to amide I (C =O stretching) and
to N-H (amine) vibration overlapped to amide II (N-H vi-
bration), respectively and, at 1064 and 1022 cm−1, two
bands that can be attributed to C-O-C and C-O vibration.
From propolis extract, typical bands at 1165 cm−1, attrib-
uted to C–O and C–OH vibration, at 1434 cm−1, attrib-
uted to C–H vibration, at 1512, 1598 and 1630 cm−1,
attributed to aromatic ring deformations and at 1681 cm−1,
attributed to C =O stretching of flavonoids and lipids,found in propolis ethanolic extract. The spectrum of PCV
showed characteristic bands both of CHV (e.g. 1079 cm−1)
and EPE (e.g. 1681, 1627, 1598, 1513 and 1434 cm−1), with
slight and no significant shifts. Moreover, the first band of
ATR-FTIR spectra was widened and stiffened to a higher
frequency compared to PCV spectrum (from 3243 to
3251 cm−1), suggesting the hydrogen bonding between chi-
tosan and propolis. There are no new bands in PCV
spectrum. The ATR-FTIR spectra of PCV 10% and 5%
showed the same pattern of PCV 15% (data not shown).
Varnish casting time
The casting times of the formulations on tooth surface
without using compressed air for CHV, PCV 15%, PCV
10% and PCV 5% were about thirty minutes (Table 3).
Although the vehicle of the varnishes does not casts fast
naturally, the casting process is accelerated by the com-
pressed air, which gives a casting time of less than five
minutes for all the formulations (Table 3). Propolis alco-
holic extract ran of the teeth and was not able to form
film on tooth surface. The films which were formed on
the teeth surface kept their integrity even after 24 hours
of immersion and shacking, but were easily removed by
brushing. No signal of change on tooth color surface
was observed after brushing.
SEM analysis
SEM pictures of CHV, PCV 15%, PCV 10%, and PCV
5% are presented on Figure 2. The arrows indicate the
film formed by the varnish. Thickness is also indicated.
From surface pictures (Figure 2c), it was observed that
the film formed was uniform and homogeneous and lat-
eral pictures showed that the film was compact and had
between 15 and 20 μm of thickness. The films were in
intimate contact with the tooth surface and no sign of
possible detachment between the film and the tooth sur-
face was indentified.
Antimicrobial susceptibility test
All concentrations of propolis-chitosan varnish inhibited
the growth of all microorganisms tested (Table 4). How-
ever, no significant difference was observed between the
varnishes of 5%, 10% and 15%. On the other hand, the
zones of inhibition were lower for anaerobic microorgan-
isms P. gingivalis and A. actinomycetemcomitans, while
larger zones of inhibition were observed for P. intermedia
and F. nucleatum . No significant difference was observed
between the zones of inhibition of the cariogenic biofilm
microorganisms S. mutans, S. sanguinis, S. salivarius and
L. casei. C. dubliniensis responded better the varnish in-
hibition when compared C. albicans and C. lusitaniae .
Both varnishes, as well as the EPE 5% (control) exhibited
higher inhibition zones for most microorganisms tested
when compared with controls CHV, NYS and CHL . The
Figure 1 ATR-FTIR spectrum of a, blank varnish (CHV); b, Ethanolic Propolis extract (EPE) and c, Propolis varnish containing 15% of
dried extract (PCV 15%).
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bactericidal concentration (MBC) for cariogenic microor-
ganisms (Table 5) were lower compared with controls
EPE, CHV and CHL.
Drug release
All of the varnish formulations have released propolis
for more than 24 hours (Figure 3). PCV 5% presented
the worst performance, releasing less than 20% of prop-
olis in 24 hours. Since after 4 weeks (672 hours) no more
propolis was released, this test was interrupted before deTable 3 Casting times (in minutes) of Propolis varnishes contai
and PCV 5%, respectively) and blank varnish (BCV), after applic
Formulation PCV 15%
Natural casting time 44.50 ± 0.35a
Compressed air helped casting time 5.63 ± 0.18b
*Different letters in the same columns means statistically significant different values
Media and Standard Deviation (M ± SD) of three experiments. Unpaired Student’s t-others. PCV 10% had an intermediate performance, releas-
ing more than 30% of the extract in 9 weeks (1512 hours),
although only 10% of propolis was released in the first
24 hours. The best sustained release profile was obtained
from PCV 15%, which released about 20% of the extract
in the first 24 hours. Propolis active components were re-
leased for more than one week.
Discussion
Since dental caries is a disease caused by multiple fac-
tors, prevention, based on common risk factors plays anning 15%, 10% and 5% of Propolis (PCV 15%, PCV 10%
ation of 50 μL of the formulation on incisive tooth surface*
PCV 10% PCV 5% BCV
40.84 ± 1.03a 37.20 ± 2.67a 31.46 ± 0.22a
4.32 ± 0.17b 3.89 ± 0.18b 2.62 ± 0.40b
.













Figure 2 (See legend on next page.)
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Figure 2 Morphological characterization of films which was formed on tooth surface after application of Chitosan-based Propolis
varnishes. SEM pictures of I: blank Chitosan varnish (BCV); II: Propolis varnishes containing 15% of Propolis extract (PCV 15%); III: Propolis
varnishes containing 10% of Propolis extract (PCV 10%); and IV: Propolis varnishes containing 5% of Propolis extract (PCV 5%); a, side view;
b, expansion of a; c, surface view.
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conducted, for example, by the removal of the microbial
deposits, oral hygiene procedures, dietary advice to in-
fluence the metabolic activity of the plaque and use of
anti-plaque chemical agents such as fluoride toothpaste,
gel and varnish [45,46].
Fluoride is the most important chemical agent used on
dental caries prevention [47] and the various topical
fluoride interventions have been supporting, over six de-
cades of experimental research, their value as anti-caries
measures [46]. But, the high prevalence of dental fluor-
osis caused concern about his use [48]. Also, there is still
a fraction of the population in which the conventional
Fluoride regimens seems to have little or no impact on
caries prevalence [49]. Moreover, an increased resistance
to caries from fluoride has been reported [50].
Antimicrobial therapy is, also, a well-based approach
on dental caries prevention [51]. Chlorhexidine, a sub-
stance with antimicrobial activity against cariogenic
microbiota, has been tried on dental care prevention
but, due to the current lack of evidence on long-term
clinical outcomes and reported side effects (e.g. yellow-
brown staining of the teeth with a mouth rinse, an al-
tered taste sensation, burning sensations of the oral soft
tissues, soreness and dryness of the oral tissues, and des-
quamative lesions and ulcerations of the gingival mu-
cosa), chlorhexidine rinse should not be recommendedTable 4 Susceptibility test of propolis- based chitosan varnish
Microorganism Inhibition zones (M ± SD) =mm
PCV
5% 10% 15%
S. mutans 20.3 ± 0.51 20.2 ± 0.88 21.0 ± 0.0
S. sanguinis 21.5 ± 0.25 21.5 ± 0.25 22.3 ± 1.1
S. salivarius 20.5 ± 0.33 20.5 ± 0.33 21.5 ± 0.5
L. casei 19.3 ± 0.25 19.3 ± 0.25 21.3 ± 0.7
P. intermedia 26.3 ± 1.03 23.3 ± 1.13 24.0 ± 0.0
P. gingivalis 13.0 ± 0.00 11.6 ± 0,23 8.30 ± 0.3
F. nucleatum 26.5 ± 0.75 22.0 ± 0.00 24.5 ± 0.2
A.actinomycetemcomitans 11.6 ± 0.54 12.6 ± 0.22 11.6 ± 0.3
C. albicans 20.5 ± 0.23 20.5 ± 0.23 21.3 ± 0.3
C. dubliniensis 24.6 ± 0.37 23.3 ± 0,82 23.3 ± 0.5
C. lusitaniae 20.3 ± 0.25 20.3 ± 0.25 20.3 ± 0.3
Abbreviations: PCV propolis-based chitosan varnish, CHV chitosan varnish, EPE ethan
Inhibition zones Media and Standard Deviation (M ± SD) of three experiments.for caries prevention. Clinical evidence on gels and var-
nishes containing this substance is also inconclusive
[52].
Propolis is a substance which is effective against cario-
genic microbiota [13,53]. But, until now, few formula-
tions containing propolis extract are used on dentistry.
Antimicrobial activity of Propolis is associated with fla-
vonoids quercetin, kaemphterol, galangin and pinocem-
brin and with fenolic acids esters [26,30,31]. Anticaries
effect of propolis is related to two different mechanisms,
such as antimicrobial activity against Streptococcus
mutans and inhibition of bacterial adherence by inhib-
ition of glucosyltransferase enzymes (GTFs) activity
[13,20], which are considered major properties in the es-
tablishment of the cariogenic process [13].
Studies have also shown that chitosan can inhibit
Streptococcus mutans during the adhesion phase and at
successive stages of accumulation displayed a significant
antibacterial and plaque reducing action [36,37], so that
chitosan effectively inhibit the initial adherence of oral
bacteria onto human tooth surface [38]. Finally, in vitro
studies have shown that chitosan interferes in the
process of the tooth enamel demineralization inhibiting
the release of mineral elements [39]. Due its interesting
properties, chitosan have been widely used in various
long lasting oral formulations [14,40-42] and exhibited
synergistic antiplaque effect when it was associated withagainst oral pathogens microorganisms
CHV EPE NYS CHL
0 10.4 ± 0.22 22.6 ± 0.66 - 19.0 ± 0.00
8 10.5 ± 0.25 21.3 ± 0.31 - 19.0 ± 0.00
0 8.30 ± 0.33 20.5 ± 0,55 - 18.5 ± 0,55
1 9.50 ± 0.55 16.0 ± 0.00 - 17.3 ± 0.33
0 10.6 ± 0.22 17.0 ± 0.00 - 20.3 ± 0.53
3 11.5 ± 0.85 14.3 ± 1.13 - 13.3 ± 0,73
5 11.0 ± 0.00 18.5 ± 1.25 - 20.0 ± 0.00
3 9.30 ± 0.33 13.0 ± 0.00 - 12.3 ± 0,52
3 9,50 ± 0.55 16.3 ± 0.52 17.0 ± 0.00 -
5 14.0 ± 0.00 16.6 ± 0.13 18.0 ± 0.00 -
1 13.0 ± 0.00 16.0 ± 0.00 19.0 ± 0.00 -
ol propolis extract, CHL chlorhexidine 0.12%, NYS nystatin.
Table 5 Antimicrobial susceptibility test
Microorganisms Antimicrobial susceptibility test
MIC (μg/mL) MBC (μg/mL)
PCV 15% CHV EPE CHX PCV 15% CHV EPE CHX
S. mutans 4,687 25.4 15.3 17.8 9,375 25.4 15.3 17.8
S. sanguinis 5,850 25.4 15.3 17.8 11,710 25.4 15.3 17.8
S. salivarius 4,687 25.4 15.3 17.8 4,687 25.4 15.3 17.8
L. casei 4,687 25.4 15.3 17.8 4,687 25.4 15.3 17.8
Abbreviations: PCV propolis-based chitosan varnish, CHV chitosan varnish, EPE ethanol propolis extract, CHX chlorhexidine 0.12%.
Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of propolis-based chitosan varnish against oral cariogenic bacteria.
Planktonic Microtitulation plates test.
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markers of Brazilian green propolis used in this study.
Table 4 shows the averages and standard deviations of
the zones of inhibition patterns of chitosan coatings and
propolis. Compared with controls isolated chitosan and
ethanolic extract of propolis is observed that there is syn-
ergism between propolis and chitosan. Varnishes demon-
strated greater effectiveness in inhibition of growth of all
microorganisms. In this study probably had a synergistic
effect between chitosan and propolis when we observe the
antimicrobial tests (Table 4).
So, in this work, we developed three pharmaceutical for-
mulations containing both chitosan and green propolis
ethanolic extract. Pharmaceutical formulations commonly
available on tooth caries prevention are toothpastes,
mouthwashes and gels, but drug activity is significantly re-
duced by these vehicles. So, long-lasting pharmaceutical
formulations like varnishes have been recently developed


















Figure 3 Sustained release profile of propolis varnishes (PCV) containpharmaceutical formulations that can form antimicrobial
tooth film and protect the tooth surface of caries [16]. The
ability to form film on tooth surface is due the presence of
polymer in the composition. In our formulations, chitosan
was the film-forming polymer.
ATR-FTIR analyses of the formulations showed that
there were no new bands in all PCV spectra, which
means that propolis constituents interact (probably due
hydrogen bonding), but did not react with chitosan to
form a new compound. This result was confirmed by
antimicrobial activity in in vitro tests, which showed syn-
ergism between the two products. Synergy is the inter-
action of multiple elements in a system to produce an
effect different from or greater than the sum of their in-
dividual effects [54].Synergism occurs when they are as-
sociated with drugs that act independently from one
another and thus potentiate the activities [55].
The regular casting time of about thirty minutes after





ing 15%, 10% and 5% of propolis.
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tion without significant casting. After a uniform layer
formation, the solvent casting can be rapidly promoted
by compressed air, which is commonly found in dentis-
try office.
The ability to form film on tooth surface was proven
by SEM analysis. Images show the formation of a con-
tinuous film, which is in intimate contact with tooth sur-
face, suggesting a strong adherence between film and
tooth surface.
The thickness of the films was dependent on propolis
concentration. Surface images (Figure 2c) suggest a
homogeneous and regular formation of the films on
tooth surface.
The in vitro antimicrobial activity was demonstrated
by agar diffusion test. As shown in the Table 4, all the
Propolis films were active against Streptococcus mutans
and leaded the same activity of chlorhexidine films used
as positive control. Although it has been described that
Chitosan can inhibit Streptococcus mutans [37,44], this
was observed in our study, however the zones of inhib-
ition were lower. The concentration of propolis extract,
5, 10 and 15%, in the film did not affect significantly the
in vitro antimicrobial activity of the formulations (see
confidence interval), probably due the poor solubility
and lower diffusion of propolis constituents on agar
[48,49]. However, important that the propolis maintains
its antimicrobial properties even when associated with
chitosan and varnish. This study demonstrated that all
tested propolis conentracoes similarly inhibited all mi-
croorganisms. This result allows to choose the varnish
concentration of 5% (5% PCV) as the best product for
continued study and thus set the dose for application in
the mouth. 5% PCV had decreased product costs, and
become the best product accepted by patients due to
the taste of propolis which had been weaker this
concentration.
As shown by SEM analysis, varnish formulations can
penetrate on tooth channels. So, we can propose that, in
varnish formulations containing 5% of propolis extract,
almost all of the extract have penetrated on tooth chan-
nels. Since it is more difficult to deliver the extract that
is on the channels, only 20% of the extract was released
in 4 weeks. In the other hand, since formulations con-
taining 10 or 15% of propolis have larger amount of
propolis, part of the extract was in the channels and part
of the extract have formed an external cover on tooth
surface. So, in these cases, the extract is sustained re-
leased over the weeks, but part of the extract which is in
the channels is not released even after 10 weeks.
For clinical applications, part of propolis should be de-
livered in the first 24 hours, in order to kill bacteria
already presented on tooth surface and, then, disrupt
cariogenic biofilm. On the other hand, since the externalvarnish film will be removed after 24 hours by brushing,
it is important to keep part of the extract on tooth chan-
nels. This extract will prevent further formations of
cariogenic biofilm. Thinking on this way, it is possible to
say that PCV will be used for clinical application because
prevent further cariogenic biofilm formation.
Conclusions
Sustained-release chitosan-based propolis varnishes were
successfully developed and characterized in this study.
The tooth surface adherence, the ability to form films
very fast, the antimicrobial activity similar to chlorhexidine
varnishes and the sustained release profile are all charac-
teristic that turns these formulations, PCV 5%, PCV 10%,
and PCV 15%, into products suitable for clinical applica-
tion on dental caries prevention field. All formulations
inhibited all tested microorganisms. Additional studies are
being conducted to evaluate the safety and the in vivo ac-
tivity of the formulations.
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